Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Autor: | Seiwert, Tanguy Y, Burtness, Barbara, Mehra, Ranee, Weiss, Jared, Berger, Raanan, Eder, Joseph Paul, Heath, Karl, McClanahan, Terrill, Lunceford, Jared, Gause, Christine, Cheng, Jonathan D, Chow, Laura Q |
---|---|
Zdroj: | In The Lancet Oncology July 2016 17(7):956-965 |
Databáze: | ScienceDirect |
Externí odkaz: |